On July, 14 2015

We are pleased to report That a key landmark event in the Evolution of Focused Ultrasound Was Achieved on March 4, 2014.
For the first time, was successfully used Focused Ultrasound in the treatment of a brain tumor. The adult patient has recurrent glioma HAD, a portion of thermally ablated using qui Was InSightec ExAblate Neuro system. The procedure for Assessment Was Performed to the Feasibility and safety of Focused Ultrasound in Treating brain tumors; It Was not Intended to Demonstrate efficacy.
The treatment Was Conducted at the FUS Center of University Children’s Hospital Zurich by a team led by Javier Fandino, MD, Professor of Neurosurgery at Kantonsspital Aarau, Switzerland and Ernst Martin, MD, Professor of Neuroradiology, University Children’s Hospital Zurich.
“The patient Was awake and responsive During The treatment, and We Were ble to successfully target and destroy a portion of the tumor Located Deep Within the patient’s brain. We are very Encouraged That We Could please use Focused Ultrasound to Accomplish this with no side or effects complications.” Said Dr. Fandino
“The Ability of Focused Ultrasound to Accomplish Both small lesions for functional neurosurgery as well as for bulk tumor ablation lesions is amazing,” added Dr. Martin.
There is an urgent need for new year Approaches to Treating brain tumors. With icts Ability to noninvasively and Accurately target and destroy diseased areas while sparing adjacent healthy brain tissue, Focused Ultrasound Could Be That the breakthrough patients and physicians-have been waiting for.
“Treatment of this patient is the first critical step in the path to Developing a new, noninvasive approach for patients with brain tumors That Could serve as an alternative to surgery or radiation therapy,” Said Neal F. Kassell, MD, Chairman of the Focused Ultrasound Foundation. “Additional clinical trials To Prove safety and efficacy are required to translate this into a treatment milestone That Could Improve the quality of life and longevity for Countless Individuals.”
The Foundation Applauds the work of the Swiss team. Brain tumors are a priority focus of the Foundation, and we-have an aggressive multi-faceted research program in place to accelerate progress.
We look forward to keeping you Informed of Major Accomplishments in the field.